CIK 0000727510 · Non-accelerated filer<br>Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222372868
- Phone
- (630) 874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-13 | COUCHMAN JONATHAN 10% owner | Sale | −50,000 | $0.39 | $19K | 350,000 |
| 2021-08-13 | COUCHMAN JONATHAN 10% owner | Sale | −57,500 | $0.39 | $22K | 2,043,024 |
| 2020-08-25 | COUCHMAN JONATHAN 10% owner | Sale | −25,000 | $0.19 | $5K | 1,590,194 |
| 2020-08-24 | COUCHMAN JONATHAN 10% owner | Sale | −52,100 | $0.18 | $10K | 1,615,194 |
| 2013-09-19 | LEBUHN ROBERT Director | Sale | −21,119 | $1.69 | $36K | 42,189 |
| 2013-09-17 | LEBUHN ROBERT Director | Sale | −34,807 | $1.74 | $60K | 63,308 |
| 2012-08-14 | LEBUHN ROBERT Director | Sale | −5,820 | $6.58 | $38K | 98,115 |
| 2012-08-10 | LEBUHN ROBERT Director | Sale | −1,933 | $6.58 | $13K | 103,935 |
| 2012-06-05 | Rackear Andrew D. VP and General Counsel | Sale | −1,614 | $6.81 | $11K | 56,720 |
| 2012-06-05 | Conover Charles SVP, R&D Program Management | Sale | −25,000 | $6.78 | $170K | 57,213 |
| 2012-03-15 | Young Richard A Director | Sale | −2,000 | $6.92 | $14K | 19,562 |
| 2011-11-10 | Rackear Andrew D. VP and General Counsel | Sale | −3,766 | $6.68 | $25K | 48,334 |
| 2011-11-08 | Buchbinder Aby VP, Clinical Development | Sale | −2,700 | $7.06 | $19K | 54,015 |
| 2011-06-01 | LEBUHN ROBERT Director | Sale | −8,702 | $10.57 | $92K | |
| 2011-02-22 | LEBUHN ROBERT Director | Sale | −10,000 | $10.88 | $109K | 96,519 |
| 2010-09-17 | HORAK IVAN D EVP, R&D, CSO | Sale | −200,000 | $10.63 | $2.1M | 120,188 |
| 2010-09-16 | HORAK IVAN D EVP, R&D, CSO | Sale | −1,700 | $10.67 | $18K | 78,188 |
| 2010-09-15 | HORAK IVAN D EVP, R&D, CSO | Sale | −57,200 | $10.81 | $618K | 77,888 |
| 2010-08-26 | LEBUHN ROBERT Director | Sale | −4,600 | $10.50 | $48K | 111,919 |
| 2010-08-26 | LEBUHN ROBERT Director | Sale | −400 | $10.51 | $4K | 111,519 |
Page 1 of 2 · 21 trades